In addition, pursuant to their terms, a proportionate adjustment will be made to the per share exercise price and number of shares issuable under all of the Company’s outstanding warrants to purchase shares of common stock, and the number of shares authorized and reserved for issuance pursuant to the Company’s equity incentive plans will be reduced proportionately. Pursuant to the Second Amended and Restated Agreement of Limited Partnership of Altus Midstream LP (“Altus Midstream”), a proportional adjustment will also be made to Altus Midstream’s outstanding common units.
After the Reverse Stock Split, the trading symbol for the Class A Common Stock will continue to be “ALTM”. The new CUSIP number for the Class A Common Stock following the Reverse Stock Split is 02215L209.
The above description of the Certificate of Amendment and the Reverse Stock Split is a summary of the material terms thereof and is qualified in its entirety by reference to the Certificate of Amendment, a copy of which is attached hereto as Exhibit 3.1, as filed with the Secretary of State of the State of Delaware effective 5:30 p.m. (Eastern Time) on June 30, 2020.
As previously reported, the Company currently has until December 28, 2020, to regain compliance with the Nasdaq’s minimum bid price requirement, and, to regain compliance, the Company’s Class A Common Stock must have a minimum bid price per share of at least $1.00 for ten consecutive business days. The principal reason for the Reverse Stock Split is to increase the per share trading price of the Company’s Class A Common Stock to help ensure a share price high enough to satisfy the $1.00 per share minimum bid price requirement. However, there can be no assurance that the Reverse Stock Split will have the desired effect of sufficiently raising the bid price of the Company’s Class A Common Stock for the required period.
In addition, on June 29, 2020, the Company issued a press release relating to the matters described in this Current Report on Form8-K. A copy of the press release is attached as Exhibit 99.1 to this report and is incorporated herein by reference.
Cautionary Statement Regarding Forward-Looking Statements
Certain statements in this Current Report on Form8-K are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “could,” “expect,” “intend,” “project,” “estimate,” “anticipate,” “plan,” “believe,” “continue,” “seek,” “guidance,” “might,” “outlook,” “possibly,” “potential,” “should,” “would,” or similar terminology, but the absence of these words does not mean that a statement is not forward-looking. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable under the circumstances, the Company can give no assurance that such expectations will prove to have been correct. Important factors that could cause actual results to differ materially from the Company’s expectations include, but are not limited to, the risks and uncertainties associated with theCOVID-19 pandemic and resulting governmental action, and the “Risk Factors” identified in the Company’s Annual Report on Form10-K for the year ended December 31, 2019, its Quarterly Report on Form10-Q for the quarterly period ended March 31, 2020, and its other periodic reports filed with the SEC. Except as required by law, the Company assumes no duty to update or revise its forward-looking statements, whether based on changes in internal estimates or expectations, new information, future developments, or otherwise.
Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits.